BridgeMD
New treatment option for AAOCA
Official title Speed-up the Diagnosis and Evaluation of anoMalous Coronary ARTery From the Aorta
ClinicalTrials.gov ID: NCT06705751
What this study is testing
- What it's testing
- Anomalous aortic origin of the coronary arteries (AAOCA) is a rare congenital disease and one of the leading causes of sudden cardiac deaths (SCD) in young athletes but also has a lethal presentation in adult age with myocardial infarction, even if not related to obstructive coronary arteries. Unfortunately, diagnostic imaging techniques, invasive assessment, and provocative stress tests have shown low sensitivity and specificity in detecting inducible ischemia, and a multimodality assessment is then necessary.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 and older
You may be able to join if
- Adult and pediatric patients (age \> 6 years) with anomalous coronary origin from the aorta (AAOCA).
- Patients in spontaneous sinus rhythm.
- Signed informed consent.
You likely can't join if
- Patients with acute and chronic inflammatory conditions such as chronic liver disease, chronic kidney failure (creatinine \> 1.5 mg/dl), and thyroid...
- Patients with arrhythmias, absence of sinus rhythm.
- Contraindications to autonomic testing.
- Patients with a known allergy to materials in recording devices.
- Female patients who are pregnant.
The study team makes the final eligibility decision.
Where it's taking place
- San Donato Milanese, Italia, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include San Donato Milanese, Italia, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.